A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body when given as Single and Multiple Doses

Trial Identifier: D8170C00001
Sponsor: MedImmune, LLC
NCTID:: NCT03362593
Start Date: December 2017
Primary Completion Date: May 2020
Study Completion Date: May 2020
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version - Part A
English version - Part B & C
English version - Part D & F
English version - Part E

Trial Locations

Country Location
United Kingdom Ruddington, United Kingdom, NG11 6JS